Pattern of bacterial and fungal infections in neutropenic pediatric patients

Iranian Journal of Medical Sciences

Volumn 33, Issue 4, 2008, Pages 202-208

  Saeidpour, M ^a   Hamedi, A K ^a   Hanachi, Parichehr ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALZAHRA UNIVERSITY   (Iran)

Author keywords

Children; Fever; Infection; Neutropenia

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BACTERIAL INFECTION; CANDIDA; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; IRAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEUTROPENIA; NEUTROPHIL COUNT; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; URINARY TRACT INFECTION;

EID: 57549112578     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Akpek G, Knight RD, Wright DG. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy. Am J Hematol 2003; 72: 13-9.
2. Boxer LA. The immunologic system and disorders: The phagocytic system: Leukopenia. In: Behrman RE, Kliegman RM, Jenson HB, editors. Nelson textbook of pediatrics. 17th edition. Philadelphia: WB Saunders; 2004. p. 717-22.
3. Marcus RE, Goldman JM. Management of infection in the neutropenic patient. Br Med J (Clin Res Ed) 1986; 293: 406-8.
4. Sharma A, Lokeshwar N. Febrile neutropenia in haematological malignancies. J Postgrad Med 2005; 51: S42-8.
5. Baltic T, Schlosser E, Bedell MK. Neutropenic fever: one institution's quality improvement project to decrease time from patient arrival to initiation of antibiotic therapy. Clin J Oncol Nurs 2002; 6: 337-40.
6. Dubey AP, Singhal D, Prakash SK. Febrile episodes in childhood malignancies. Indian Pediatr 2002; 39: 952-7.
7. de Lalla F. Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations. Drugs 1997; 53: 789-804.
8. Mahmud S, Ghafoor T, Badsha S, Gul MS. Bacterial infections in paediatric patients with chemotherapy induced neutropenia. J Pak Med Assoc 2004; 54: 237-43.
9. Viscoli C, Castagnola E, Giacchino M, et al. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999; 35: 770-4.
10. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99: 580-8.
11. Viscoli C, Moroni C, Boni L, et al. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer. Rev Infect Dis 1991; 13: 397-404.
12. Roguin A, Kasis I, Ben-Arush MW, et al. Fever and neutropenia in children with malignant disease. Pediatr Hematol Oncol 1996; 13: 503-10.
13. Jones GR, Konsler GK, Dunaway RP, Pusek SN. Infection risk factors in febrile, neutropenic children and adolescents. Pediatr Hematol Oncol 1996; 13: 217-29.
14. Hodgson-Viden H, Grundy PE, Robinson JL. Early discontinuation of intravenous antimicrobial therapy in pediatric oncology patients with febrile neutropenia. BMC Pediatr 2005; 5: 10.
15. Mutnick AH, Kirby JT, Jones RN. CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance. Ann Pharmacother 2003; 37: 47-56.
16. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-40.
17. Ahmad Naqvi S M, Kehkashan Siraj, Zulfiqar A Bhutta. Febrile neutropenia in childhood malignant disorders; clinical correlates and prognostic factors. Pak Paed J Mar 1996; 20: 29-32.
18. Burney IA, Farooqui BJ, Siddiqui T, Khurshid M. The spectrum of bacterial infections in febrile neutropenic patients: effect on empiric antibiotic therapy. J Pak Med Assoc 1998; 48: 364-7.
19. Fleischhacka G, Hartmanna C, Simona A. Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 2001; 47: 841-53.
20. Viscoli C. The evolution of the empirical management of fever and neutropenia in cancer patients. J Antimicrob Chemother 1998; 41: 65-80.
21. Cometta A, Calandra T, Gaya H, et al. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother 1996; 40: 1108-15.
22. Maldini B, Antolić S, Sakić-Zdravcević K, et al. Evaluation of bacteremia in a pediatric intensive care unit: epidemiology, microbiology, sources sites and risk factors. Coll Antropol 2007; 31: 1083-8.
23. Donowitz GR, Maki DG, Crnich CJ, et al. Infections in the neutropenic patient - new views of an old problem. Hematology Am Soc Hematol Educ Program 2001: 113-39.
24. Schimpff S, Satterlee W, Young VM, Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971; 284: 1061-5.
25. Giamarellou H, Antoniadou A. Infectious complications of febrile leukopenia. Infect Dis Clin North Am 2001; 15: 457-82.
26. Cohen J, Donnelly JP, Worsley AM, et al. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet 1983; 2: 1452-4.
27. Seibel NL, Schwartz C, Arrieta A, et al. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother 2005; 49: 3317-24.